← All stocks

CERUS CORP

CERS Mostly scheduled

CIK 0001020214 #3009 in the set updated 17 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$3.09M

$3.03M on a plan · $0.00 straight out of an exercise

Sold at will

$53.18K

1 of 22 sales

Net

−$3.09M

−$53.18K against sales at will

By person

13 insiders · 22 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Greenman William Mariner

President and CEO

—

$1.20M (3) scheduled

−$1.20M

5,053,036

2.51%

$15.08M

+42.0%

Jayaraman Vivek K

Chief Executive Officer

—

$619.47K (6) scheduled

−$619.47K

2,232,211

1.11%

$6.66M

+120.9%

Green Kevin Dennis

Chief Financial Officer

—

$480.12K (4) scheduled

−$480.12K

1,062,188

0.5271%

$3.17M

+123.8%

Benjamin Richard J

Chief Medical Officer

—

$419.54K (4) scheduled

−$419.54K

777,361

0.3857%

$2.32M

+77.5%

Jensen Chrystal

Chief Legal Officer

—

$316.49K (4) scheduled

−$316.49K

936,657

0.4648%

$2.80M

+146.1%

BJERKHOLT ERIC

Director

—

$53.18K (1)

−$53.18K

261,679

0.1298%

$780.93K

+43.7%

Witney Frank

Director

—

340,059

0.1687%

$1.01M

+54.5%

NACHTSHEIM JAMI K

Director

—

268,362

0.1332%

$800.87K

+80.9%

Lucena Ann

Director

—

232,284

0.1153%

$693.21K

+106.9%

Swisher Daniel N JR

Director

—

207,045

0.1027%

$617.88K

+40.8%

MOORE TIMOTHY L.

Director

—

205,073

0.1018%

$612.00K

+41.4%

Shan Hua

Director

—

192,386

0.0955%

$574.14K

+165.8%

Gregory Dean A.

Director

—

146,725

0.0728%

$437.87K

+144.5%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 33

Amendments (4/A) skipped 1

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 21

Sales straight out of an exercise 0

Sales at will 1

Transactions with no price 0

Shares from compensation/vesting 4,637,513

History held since 16 Sep 2016